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Most tumors affecting the extrahepatic bile duct are 
adenocarcinomas; the other histologic types occur on-
ly rarely. We herein report the extremely rare case of 
signet ring cell carcinoma (SRCC) originating from the 
extrahepatic bile duct. A 55-year-old man was hospi-
talized for jaundice and pruritus. Computed tomog-
raphy and positron emission tomography suggested 
the presence of distal extrahepatic bile-duct cancer. 
He underwent a pylorus preserving pancreaticoduo-
denectomy. A histologic study confirmed a signet ring 
cell neoplasm of the distal common bile duct. 
Because the upper resection margin was invaded by 
the tumor, he received postoperative concurrent che-
moradiotherapy and four cycles of chemotherapy. The 
patient has survived with no evidence of recurrence 
for 2 years. This is the second case of primary 
SRCC of the distal extrahepatic bile duct reported in 
the literature; further reports of cases are warranted 
to determine the nature of SRCC in the extrahepatic 
bile duct. (Gut Liver 2010;4:402-406)
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INTRODUCTION
  Most cholangiocarcinomas involve the perihilar and dis-
tal extrhepatic bile ducts. About two thirds are perihilar 
tumors, about one fourth are distal extrahepatic tumors, 
and the others are intrahepatic tumors.1,2 Cholangiocarci-
nomas are usually adenocarcinomas. Other less common 
histologic variants are papillary carcinoma and mucinous 
carcinoma. And the rare conditions, which occur in less 
than 5 percent of cases, include squamous-cell carcinoma, 
small-cell carcinoma, and mesenchymal tumors.3 Signet 
ring cell carcinoma (SRCC) is commonly found in the 
stomach and there is only one reported case of signet 
ring cell carcinoma in the extrahepatic bile duct.4 We 
herein report a case of 55-year-old man with SRCC in the 
extrahepatic bile duct.
CASE REPORT
  A 55-year-old male was hospitalized for jaundice and 
pruritus. Upon physical examination, he presented with 
icteric sclera and visible jaundice. Blood chemistry tests 
showed total bilirubin 4.5 mg/dL, aspartate amino-
transferase (AST) 19 IU/L, alanine aminotransferase (ALT) 
105 IU/L, alkaline phosphatase (ALP) 453 IU/L, γ-gluta-
myltransferase (GGT) 380 IU/L, and lipase 97 U/L. The 
serum electrolytes, urea nitrogen, and creatinine were 
normal. Tumor marker, carbohydrate antigen (CA) 19-9 
was slightly elevated up to 45.9 U/mL. Computed tomog-
raphy (CT) showed a hypervascular mass at the distal 
common bile duct and ampulla of Vater (Figs. 1 and 2). 
The intrahepatic bile duct and extrahepatic bile duct were 
proportionally dilated. Positron emission tomography 
(PET) showed increased 18fluoro-2-deoxyglucose (FDG) 
uptake in the distal extrahepatic bile duct and the others 
were not remarkable (Fig. 3). Biopsy samples from the 
ampulla of Vater by endoscopic retrograde cholangioscope 
(Fig. 4) showed metastatic SRCC because there were tu-
mor cells only in lamina propria and no transitional zone 
in biopsy samples from the ampulla of Vater. Samples 
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Fig. 1. Coronal view of computed tomography demonstrating 
the periampullary mass lesion and dilatation of the common 
bile duct.
Fig. 2. Axial view of computed tomography showing the 2 cm
sized mass lesion (arrow) in the distal common bile duct.
Fig. 3. Positron emission tomography showing increased 
18
F-FDG uptake in the lower common bile duct and no distant 
metastasis.
Fig. 4. Endoscopic retrograde cholangioscopy showing the 
swollen papilla of Vater with a erosive mucosa.
from the distal extrahepatic bile duct showed no malig-
nancy due to insufficient material. The endoscopic retro-
grade cholangiography revealed the protruded and en-
gorged ampulla of Vater. The common bile duct and in-
trahepatic bile duct were markedly dilated. There was 
complete obstruction at the distal common bile duct. To 
decompress the biliary system, an endoscopic retrograde 
biliary drainage tube was inserted (Fig. 5). 
  Esophagogastroduodenoscope and colonoscope for eval-
uation of the common primary site of signet ring cell car-
cinoma did not show any abnormality. 
  The patient underwent a pylorus preserving pancreati-
coduodenectomy (PPPD) with extended lymph node dis-
section including paraarotic lymph nodes. On gross evalu-
ation of the resected specimen, the wall of the common 
bile duct was thickened predominantly at the distal part 
measuring up to 1 cm. The cut surface of the thickened 
common bile duct wall showed concentric fibrosis and in-
tervening gray tan areas (Fig. 6). The lesion was con-
nected to the duodenal muscle and pancreatic paren-
chyma. A few gray colored myxoid nodules were noted in 
the perimuscular connective tissue of the common bile 
duct. The ampulla of Vater was not prominant, grossly. 
The proximal part of common bile duct was slightly 
dilated. The cystic duct, gallbladder, and duodenal mucosa 
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Fig. 5. Endoscopic retrograde cholangioscopy showing the 
plastic biliary stent inserted in the distal common bile duct.
Fig. 6. Surgical specimen showing the thickened wall of the 
common bile duct measuring up to 1 cm. 
P, pancreatic duct; T, tumor mass; PC, pancreas.
Fig. 7. The ampullar of Vater showing normal feature grossly 
and slight dilatation of the proximal common bile duct. 
D, duodenum; C, common bile duct; P, pancreatic duct; G, 
gallbladder; CD, cystit duct; T, tumor mass; PC, pancreas.
Fig. 9. Signet ring cell distal common bile duct cancer (H&E 
stain, ×100).
Fig. 8. Gastric metaplasia in distal common bile duct mucosa 
(H&E stain, ×40).
were grossly unremarkable (Fig. 7).
  The histology of the main tumor mass revealed SRCC 
(Figs. 8 and 9) invading perimuscular soft tissue and in-
volving pancreatic parenchyma, ampulla of Vater, duode-
nal submucosa, and myenteric plexus. Extensive neural 
invasion and mucin pool formation were also detected. 
The tumor cells were found in a ruptured peripancreatic 
node. And tumor cells were noted on the proximal re-
section margin of common bile duct. With these histo-
logic finidings, the patient was confirmed to T3N1M0, 
stage IIB signet ring cell carcinoma of the distal common 
bile duct with R1 resection status. 
  He was taken postoperative concurrent chemoradio-
therapy with total radiation dose of 50.4 Gray on the tu-
mor bed. The combination of gemcitabine and cisplatin 
was used for chemotherapeutic regimen of concurrent 
chemoradiotherapy. After that, he underwent additional 4 
cycles of gemcitabine and cisplatin chemotherapy until 
now without any evidence of recurrence.
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DISCUSSION
  The incidence of bile duct tumors in large autopsy 
studies varies from 0.01% to 0.2%, and may constitute 
about 2% of all reported cancer.1,3 Tumors of the distal 
extrahepatic bile duct represent approximately 20% to 
30% of all bile duct cancers and 5% to 10% of all peri-
ampullary tumors.1,5 The majority of patients are over 65 
years of age, and the peak incidence occurs in the seventh 
decade of life.5
  SRCC of the biliary system is extremely rare and most 
SRCCs of the biliary system are originated from 
gallbladder. Currently, only one case of SRCC from the 
lower bile duct has been reported in the English 
literature.4 And this case is the second case of primary 
signet ring cell carcinoma of the distal extrahepatic bile 
duct reported in literature.
  Commonly, bile duct cancer spreads longitudinally 
along the bile duct wall and connective tissue. It can go 
through the submucosa in spite of intact epithelial lining. 
Because the extent of ductal tumor spread is difficult to 
know preoperatively, the intraopertive frozen section anal-
ysis is important to determine the degree of submucosal 
spreading and to spare tumor-free resection margin.3,6,7 
Wakai et al.8 suggested that ductal margin status was a 
strong independent prognostic factor and invasive ductal 
carcinoma at resection margin appeared to have a strong 
adverse effect on patient survival. In this case, resection 
margin was clear in intraoperative frozen section analysis, 
but proximal resection margin was invaded by tumor in 
final pathologic report. It has long been suggested that 
extrahepatic bile duct tumors progress slowly.9 However, 
progression can be rapid in some patients. In general, 
SRCCs of other digestive organs progress rapidly and 
have a poor prognosis.10-12 Hiraki et al.4 reported one case 
of extrahepatic SRCC of rapid growth and aggressive 
nature. It is unclear whether the progression is more rap-
id in patients with SRCCs than patients with other type 
tumors because of extreme rarity. In this case, the patient 
is still alive without visible remnant lesion after surgery 
and chemoradiotherapy. 
  The origin of SRCCs in periampullary area is not 
known well. There are two possible explanations for this 
histologic variation. One explanation is that the tumors 
may arise from ectopic gastric mucosa. Indeed, there are 
some reported cases of SRCCs with ectopic gastric muco-
sa in ampullary tumors. Another explanation suggests 
that SRCCs may develop from gastric-type epithelial 
metaplasia. The presence of duodenal ulcer and elevated 
intraluminal acidity may irritate epithelial lining and can 
induce gastric-type metaplasia. It can be etiology of the 
periampullary SRCCs.12-14 At the present case, no ectopic 
gastric mucosa and epithelial metaplasia was found in 
surgical specimen of the duodenum. The patients also did 
not have a previous history of peptic ulcer disease. In this 
case, we could make differential diagnosis between the 
distal common bile duct cancer and the ampulla of Vater 
cancer, as there were transitional zone from mural gland 
to signet ring cell carcinoma in distal portion of the com-
mon bile duct.
  In conclusion, curative therapy may be possible with 
surgery and adjuvant therapy in SRCC of distal extra-
hepatic bile duct. But due to extreme rarity of this dis-
ease, additional case reports are warranted to decide the 
nature and optimal management of the disease.
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